Antitrypanosomal activities of proteasome inhibitors

Seven peptidyl proteasome inhibitors were tested for in vitro activity against Trypanosoma brucei bloodstream forms. Two compounds showed activity in the low nanomolar range. In general, trypanosomes were more susceptible to the compounds than were human HL-60 cells. The data support the potential o...

Full description

Saved in:
Bibliographic Details
Main Authors: Nkemngu, Njinkeng (Author) , Rosenkranz, Vera (Author) , Wink, Michael (Author) , Steverding, Dietmar (Author)
Format: Article (Journal)
Language:English
Published: 2002
In: Antimicrobial agents and chemotherapy
Year: 2002, Volume: 46, Issue: 6, Pages: 2038-2040
ISSN:1098-6596
DOI:10.1128/AAC.46.6.2038-2040.2002
Online Access:Verlag, Volltext: http://dx.doi.org/10.1128/AAC.46.6.2038-2040.2002
Get full text
Author Notes:Joseph Nkemgu-Njinkeng, Vera Rosenkranz, Michael Wink and Dietmar Steverding
Description
Summary:Seven peptidyl proteasome inhibitors were tested for in vitro activity against Trypanosoma brucei bloodstream forms. Two compounds showed activity in the low nanomolar range. In general, trypanosomes were more susceptible to the compounds than were human HL-60 cells. The data support the potential of proteasome inhibitors for rational antitrypanosomal drug development.
Item Description:Gesehen am 05.10.2017
Physical Description:Online Resource
ISSN:1098-6596
DOI:10.1128/AAC.46.6.2038-2040.2002